Table 1.

Cross analysis of clinical information from OSCC patients and their score of NETs.

Variables	Cases [number, %]	Score of NETs [number, %]
		Low Group	High Group	P value
Age [years]				0.818
≤ 60	92 [44.9%]	49 [44.1%]	43 [45.7%]
> 60	113 [55.1%]	62 [55.9%]	51 [54.3%]
Gender				0.090
Male	122 [59.5%]	72 [64.9%]	50 [53.2%]
Female	83 [40.5%]	39 [35.1%]	44 [46.8%]
Pathological differentiation				0.001*
I	132 [64.4%]	84 [75.7%]	48 [51.1%]
II	60 [29.3%]	24 [21.6%]	36 [38.3%]
III	13 [6.3%]	3 [2.7%]	10 [10.6%]
T stage				<0.001*
T1	36 [17.6%]	27 [24.3%]	9 [9.6%]
T2	104 [50.7%]	63 [56.8%]	41 [43.6%]
T3	49 [23.9%]	14 [12.6%]	35 [37.2%]
T4	16 [7.8%]	7 [6.3%]	9 [9.6%]
Lymph node metastasis				< 0.001*
N0	129 [62.9%]	92 [82.9%]	37 [39.4%]
N1	41 [20.0%]	7 [6.3%]	34 [36.2%]
N2	35 [17.1%]	12 [10.8%]	23 [24.5%]
Invasion				0.003*
No	86 [42.0%]	57 [51.4%]	29 [30.9%]
Yes	119 [58.0%]	54 [48.6%]	65 [69.1%]
Recrudescence				0.014*
No	154 [75.1%]	91 [82.0%]	63 [67.0%]
Yes	51 [24.9%]	20 [18.0%]	31 [33.0%]
Death				0.010*
No	179 [87.3%]	101 [92.8%]	76 [80.9%]
Yes	26 [12.7%]	8 [7.2%]	18 [19.1%]
Number of neutrophil				0.461
< 2 × 109	11 [5.4%]	4 [3.6%]	7 [7.4%]
2 × 109 –7 × 109	188 [91.7%]	104 [93.7%]	84 [89.4%]
> 7 × 109	6 [2.9%]	3 [2.7%]	3 [3.2%]
Neutrophil–lymphocyte ratio				0.005*
< 50%	19 [9.3%]	11 [9.9%]	8 [8.5%]
50%–70%	161 [78.5%]	94 [84.7%]	67 [71.3%]
> 70%	25 [12.2%]	6 [5.4%]	19 [20.2%]

The p-values were obtained using the chi-square test. The asterisks indicate the p-values: *< 0.05.